Archives

  • Special Supplement, November 2023

    • Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases: The Powerful Pill

  • Volume 1, Issue 3, October 2023

    • Bringing STRIDE2 to Life in Clinical Practice
    • Practical Approach to Abnormal Liver Enzymes in Patients with Inflammatory Bowel Disease
    • Colorectal Neoplasia Surveillance in Inflammatory Bowel Disease: Updates and Practical Approaches
    • Management of Clostridioides Difficile in IBD Patients
    • Today and Tomorrow: The Use of Biomarkers in Inflammatory Bowel Disease

  • Volume 1, Issue 2, June 2023

    • Surgical Approaches to Perianal Crohn's Disease
    • Advanced Combination Therapy in IBD: Can It Be Achieved With Success?
    • Cutaneous Manifestations of Inflammatory Bowel Disease: Clinical Pearls for Gastroenterologists
    • Post-Operative Crohn's Disease: Current and Emerging Management Techniques
    • Vaccine-Preventable Disease in IBD: Relevance, Guidelines, and Considerations for Implementation
  • issue cover

    Special Supplement, May 2023

    • Targeting IL23p19 Using Risankizumab for the Management of Moderate-to-Severely Active Crohn's disease: The Next Frontier?

  • Volume 1, Issue 1, April 2023

    • JAK Inhibitors for the Treatment of Inflammatory Bowel Disease
    • Management of Pouchitis: Clinical Pearls for the Gastroenterologist
    • Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: Where Has the Pendulum Swung?
    • Approach to Management of Inflammatory Bowel Disease-Related Arthritis
    • Malnutrition Assessment in Patients with Inflammatory Bowel Disease